Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 | Patent: 672 | |||
2 | Patent: 579 | |||
3 | Patent: 169 | |||
4 | Patent: 149 | |||
5 | Patent: 109 | |||
6 | Patent: 70 | |||
7 | Patent: 54 | |||
8 | Patent: 48 | |||
9 | Patent: 27 | |||
10 | Patent: 26 |
Top 10 Key Players companies in Monoclonal antibody
by Most Patent Filings in the Switzerland in 2021
The Monoclonal antibody top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filings Monoclonal antibody Key Players in the Switzerland. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.
Page generation time:
Jul 17 2025